It has been demonstrated that deficiency in sGC-derived cyclic guanosine monophosphate (cGMP) induced by low NO bioavailability leads to myocardial dysfunction and endothelial dysfunction in coronary microcirculation. This evidence concerns the gene SGCB and endothelial dysfunction.